Clinical Study of ALT-BB4 to Determine Tolerance, Safety and Pharmacokinetics in Healthy Volunteer

NCT05232175 · clinicaltrials.gov ↗

PHASE1

Phase

COMPLETED

Status

290

Enrollment

INDUSTRY

Sponsor class

Conditions

Health, Subjective

Interventions

DRUG: ALT-BB4
DRUG: 0.9%NaCl

Sponsor

Alteogen, Inc.